Mon, 21 November 2011
Drs. Ben Solomon (Peter MacCallum Cancer Center in Melbourne) and Ross Camidge (Univ. of Colorado) answer Qs on ALK rearrangements and crizotinib (XALKORI) for advanced non-small cell lung cancer (NSCLC).
Direct download: GRACEcast-086_Lung-Video_Solomon_Camidge_ALK_QnA.m4v
Category:Lung-Cancer-Video -- posted at: 8:00am PST |